Ongoing study: https://pubmed.ncbi.nlm.nih.gov/39780249/

Usual rant to news outlets: Cite your damn sources! (if they are public, which is the case here). This is a web page, not printed paper, web pages support links, links are not just for ads!

I'm sure this isn't the last we will hear of the potential of GLP1s in neurological diseases.

At the same time, our work in neurostimulation of slow-wave sleep is showing promise with a correlation between neurostimulation response, amyloid response, and memory in healthy older adults[1], as well as tolerance of stimulation in people living with Alzheimer's [2]. More studies to be done, but if you're curious, we link to a large body of research on our website https://www.affectablesleep.com/how-it-works?type=All#resear...

[1] https://doi.org/10.1093/ageing/afad228 [2] https://doi.org/10.1016/j.jagp.2024.07.002

Alzheimer's isn't one thing but a category of degenerative pathologies.

Probably also requires holistic improvements in lifestyle ( hydration, sleep, exercise, diet (not just quantity)), gene in/activation, &| vaccines for TAU &| β-amyloid.

PS: I wonder if nootropics will be developed to emulate or enhance the effects of exercise.